Recent Quotes

My Watchlist

Indicators

NeuroSense Therapeutics Ltd. - Ordinary Shares (NQ: NRSN )

1.290 UNCHANGED

Streaming Delayed Price Updated: 3:55 PM EST, Nov 8, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	23,982
Open	1.300
Bid (Size)	1.300 (5)
Ask (Size)	1.370 (1)
Prev. Close	1.290
Today's Range	1.260 - 1.300
52wk Range	0.4313 - 2.330
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

EXCLUSIVE: Nano-Cap NeuroSense Schedules FDA Meeting To Advance Lead Program And Marketing Application Submission

October 28, 2024

NeuroSense Therapeutics schedules an FDA Type C meeting on Nov. 6 to finalize its Phase 3 trial design for PrimeC, a potential ALS treatment.

Via Benzinga

NeuroSense Advances Plans For Early Commercialization Of Potentially Groundbreaking ALS Treatment In Canada, Targeting A $100M+ Market

October 17, 2024

NeuroSense Advances Plans For Early Commercialization Of Potentially Groundbreaking ALS Treatment In Canada, Targeting A $100M+ Market

Via News Direct

Performance

YTD	+61.25%	+61.25%
1 Month	+5.44%	+5.44%
3 Month	+95.75%	+95.75%
6 Month	+9.32%	+9.32%
1 Year	+143.40%	+143.40%

More News

EXCLUSIVE: NeuroSense Therapeutics In Advanced Talks With Several Multi-Billion-Dollar Pharma Companies To Partner Its Lead Drug

August 28, 2024

Via Benzinga

NRSN Stock Earnings: NeuroSense Therapeutics Misses EPS for Q1 2024

June 24, 2024

Via InvestorPlace

NRSN Stock Earnings: NeuroSense Therapeutics Beats EPS for Q4 2023

April 05, 2024

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

March 15, 2024

Via InvestorPlace

NeuroSense's (NASDAQ: NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024

January 29, 2024

Via Benzinga

Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

December 06, 2023

Via Benzinga

US Stocks Higher; Private Payrolls Rise By 103,000 In November

December 06, 2023

Via Benzinga

Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket

December 06, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

December 06, 2023

Via InvestorPlace

Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

December 05, 2023

Via Benzinga

Why GitLab Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

December 05, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

December 05, 2023

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

November 17, 2023

Via InvestorPlace

Renowned ALS Researcher Confirms The Efficacy Of NeuroSense Therapeutics’ Lead Drug Candidate, PrimeC

October 19, 2023

Via ACCESSWIRE

Renowned ALS Researcher Confirms The Efficacy Of NeuroSense Therapeutics' Lead Drug Candidate, PrimeC

October 18, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday

September 29, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 17, 2023

July 17, 2023

Via Benzinga

Why Pliant Therapeutics Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket

January 23, 2023

Via Benzinga

Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

January 20, 2023

Via Benzinga

Dow Drops 50 Points; Netflix Sales Top Estimates

January 20, 2023

Via Benzinga

Why Netflix Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

January 20, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

January 20, 2023

Via InvestorPlace

Dow Drops 150 Points; Crude Oil Up 1%

January 19, 2023

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.